Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$97.21M
Total Bought:
$30.34M
Total Sold:
$23.01M
Net Transaction:
+$7.34M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$10.69M$15.37M15.81%+$4.68M
Acelyrin Inc03,366,945+3,366,945$0$8.32M8.56%+$8.32M
Springworks Therapeutics Inc185,520185,5200$6.70M$8.19M8.42%+$1.48M
Protara Therapeutics, Inc.(TARA)1,579,0001,667,800+88,800$8.34M$7.10M7.31%-$1.23M
Praxis Precision Medicines, Inc.(PRAX)300,000185,000-115,000$23.09M$7.01M7.21%-$16.08M
Tourmaline Bio Inc423,795455,412+31,617$8.59M$6.93M7.13%-$1.67M
Jasper Therapeutics, Inc.(JSPR)1,433,8281,433,8280$30.66M$6.17M6.34%-$24.49M
Verona Pharma PlcADS50,00095,000+45,000$2.32M$6.03M6.20%+$3.71M
Zevra Therapeutics, Inc.(ZVRA)300,000665,000+365,000$2.50M$4.98M5.12%+$2.48M
Liquidia Corporation(LQDA)300,000300,0000$3.53M$4.42M4.55%+$897.0K
InspireMD, Inc.(NSPR)904,029904,0290$2.38M$2.43M2.50%+$54.2K
Scpharmaceuticals Inc0917,668+917,668$0$2.41M2.48%+$2.41M
Mineralys Therapeutics, Inc.(MLYS)0150,600+150,600$0$2.39M2.46%+$2.39M
Replimune Group, Inc.(REPL)181,367182,083+716$2.20M$1.78M1.83%-$421.0K
Edesa Biotech, Inc.(EDSA)0687,500+687,500$0$1.68M1.73%+$1.68M
Instil Bio, Inc.(TIL)069,000+69,000$0$1.20M1.23%+$1.20M
Rezolute, Inc.(RZLT)800,000400,000-400,000$3.92M$1.16M1.19%-$2.76M
Eledon Pharmaceuticals, Inc.(ELDN)323,973323,9730$1.33M$1.10M1.13%-$236.5K
Perspective Therapeutics, Inc.(CATX)500,000500,0000$1.59M$1.06M1.10%-$530.0K
Geron Corporation(GERN)49,000655,000+606,000$173.5K$1.04M1.07%+$868.0K
Immunome, Inc.(IMNM)0153,500+153,500$0$1.03M1.06%+$1.03M
TELA Bio, Inc.(TELA)0747,410+747,410$0$911.8K0.94%+$911.8K
Avalo Therapeutics, Inc.(AVTX)109,972111,972+2,000$817.1K$896.9K0.92%+$79.8K
Sutro Biopharma, Inc.(STRO)30,0001,030,000+1,000,000$55.2K$670.1K0.69%+$614.9K
Upstream Bio, Inc.(UPB)0107,000+107,000$0$654.8K0.67%+$654.8K
Tenax Therapeutics, Inc.(TENX)83,33383,3330$515.8K$545.8K0.56%+$30.0K
Kiora Pharmaceuticals, Inc.(KPRX)122,223122,2230$403.3K$367.9K0.38%-$35.4K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)56,70059,000+2,300$669.1K$313.3K0.32%-$355.8K
Regulus Therapeutics Inc70,00080,000+10,000$110.6K$140.0K0.14%+$29.4K
Wave Life Sciences, Inc.SHS(WVE)13,00013,0000$160.8K$105.0K0.11%-$55.8K
Gossamer Bio, Inc.(GOSS)75,00075,0000$67.8K$82.5K0.08%+$14.7K
Erasca, Inc.(ERAS)050,000+50,000$0$68.5K0.07%+$68.5K
Alector Inc55,00055,0000$104.0K$67.7K0.07%-$36.3K
Larimar Therapeutics, Inc.(LRMR)18,00028,000+10,000$69.7K$60.2K0.06%-$9.5K
Proqr Thrapeutics N VSHS EURO
SHS EURO
40,50045,000+4,500$107.3K$59.9K0.06%-$47.5K
Context Therapeutics Inc.(CNTX)90,00090,0000$94.5K$55.1K0.06%-$39.4K
Design Therapeutics, Inc.(DSGN)014,000+14,000$0$54.0K0.06%+$54.0K
Aclaris Therapeutics, Inc.(ACRS)27,00035,000+8,000$67.0K$53.5K0.06%-$13.4K
CytomX Therapeutics, Inc.(CTMX)35,00075,000+40,000$36.0K$47.7K0.05%+$11.6K
Terns Pharmaceuticals Inc17,00017,0000$94.2K$46.9K0.05%-$47.3K
Ventyx Biosciences Inc35,00040,000+5,000$76.7K$46.0K0.05%-$30.6K
4d Molecular Therapeutics In10,00012,000+2,000$55.7K$38.8K0.04%-$16.9K
PMV Pharmaceuticals, Inc.(PMVP)35,00035,0000$52.9K$38.1K0.04%-$14.7K
Ovid Therapeutics Inc.(OVID)70,00097,000+27,000$65.4K$30.3K0.03%-$35.1K
Kronos Bio Inc35,00035,0000$33.3K$28.9K0.03%-$4.4K
Nextcure Inc25,00025,0000$19.3K$12.0K0.01%-$7.3K
Elevation Oncology Inc45,00045,0000$25.3K$11.7K0.01%-$13.7K
Bolt Biotherapeutics Inc50,0000-50,000$26.8K$0—-$26.8K
Cocrystal Pharma, Inc.(COCP)10,0000-10,000$20.2K$0—-$20.2K
Collegium Pharmaceutical, Inc.(COLL)28,6850-28,685$821.8K$0—-$821.8K
Enanta Pharmaceuticals, Inc.(ENTA)13,0000-13,000$74.8K$0—-$74.8K
Fibrogen Inc80,0000-80,000$42.4K$0—-$42.4K
Karyopharm Therapeutics Inc.(KPTI)40,0000-40,000$27.1K$0—-$27.1K
Kura Oncology, Inc.(KURA)150,0000-150,000$1.31M$0—-$1.31M
Nurix Therapeutics, Inc.(NRIX)97,8890-97,889$1.84M$0—-$1.84M
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q1 2025 | TickerTrail